Cargando…

Management of cardiac arrhythmias in paediatric patients with TANGO2-deficiency disorder

FUNDING ACKNOWLEDGEMENTS: Type of funding sources: None. BACKGROUND: TANGO2-deficiency disorder (TDD) is a rare paediatric condition caused by bi-allelic mutations in the TANGO2 gene. TDD is characterised by susceptibility to metabolic crises with rhabdomyolysis, encephalopathy, lactic acidosis, hyp...

Descripción completa

Detalles Bibliográficos
Autor principal: Sarquella Brugada, G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207009/
http://dx.doi.org/10.1093/europace/euad122.351
_version_ 1785046354017386496
author Sarquella Brugada, G
author_facet Sarquella Brugada, G
author_sort Sarquella Brugada, G
collection PubMed
description FUNDING ACKNOWLEDGEMENTS: Type of funding sources: None. BACKGROUND: TANGO2-deficiency disorder (TDD) is a rare paediatric condition caused by bi-allelic mutations in the TANGO2 gene. TDD is characterised by susceptibility to metabolic crises with rhabdomyolysis, encephalopathy, lactic acidosis, hypothyroidism and difficult to manage tachyarrhythmias. AIM: We describe the electrocardiographic (ECG) findings at baseline and during metabolic crises in patients with TDD. METHODS: Retrospective, single-centre, case series study of patients with TDD (<18 years), with ECG and subcutaneous Holter monitoring, both during metabolic crises and compensated phases. RESULTS: During the period 2013-2021, 12 patients with TDD were found (median age 6.8 years, IQR 2-11.5 years). In the inter-crisis period, bradyarrhythmias were evidenced: 2/12 patients presented sinus bradycardia, 2/12 pauses of 4 and 10 seconds, 1/12 Wenckebach type block; and tachyarrhythmias: 1/12 presented paroxysmal supraventricular tachycardia and 1/12 flutter. 25% had long QT during non-acute phases (median QTc max 476 ms, IQR 456ms-530ms). There were 14 hospitalisations for metabolic crises. 57.1% had QTc interval prolongation, 35.7% ventricular tachycardias (4/14 monomorphic VT, 1/14 torsade de prongs) and 1/14 Brugada type 3 pattern. Three patients died in the context of severe metabolic acidosis and multi-organ involvement (2/12 due to VT and 1/12 due to cardiogenic shock, bradycardia associated with QTc of 635ms and severe ventricular dysfunction). CONCLUSIONS: In paediatric patients with TDD, the most frequent ECG abnormality was QTc interval prolongation with or without metabolic crises. There is a high risk of tachyarrhythmias, mainly VT, being the main cause of death in children with TDD. Subcutaneous Holter monitoring is recommended. During metabolic crises, there should be close ECG monitoring.
format Online
Article
Text
id pubmed-10207009
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-102070092023-05-25 Management of cardiac arrhythmias in paediatric patients with TANGO2-deficiency disorder Sarquella Brugada, G Europace 13.5 - Prevention FUNDING ACKNOWLEDGEMENTS: Type of funding sources: None. BACKGROUND: TANGO2-deficiency disorder (TDD) is a rare paediatric condition caused by bi-allelic mutations in the TANGO2 gene. TDD is characterised by susceptibility to metabolic crises with rhabdomyolysis, encephalopathy, lactic acidosis, hypothyroidism and difficult to manage tachyarrhythmias. AIM: We describe the electrocardiographic (ECG) findings at baseline and during metabolic crises in patients with TDD. METHODS: Retrospective, single-centre, case series study of patients with TDD (<18 years), with ECG and subcutaneous Holter monitoring, both during metabolic crises and compensated phases. RESULTS: During the period 2013-2021, 12 patients with TDD were found (median age 6.8 years, IQR 2-11.5 years). In the inter-crisis period, bradyarrhythmias were evidenced: 2/12 patients presented sinus bradycardia, 2/12 pauses of 4 and 10 seconds, 1/12 Wenckebach type block; and tachyarrhythmias: 1/12 presented paroxysmal supraventricular tachycardia and 1/12 flutter. 25% had long QT during non-acute phases (median QTc max 476 ms, IQR 456ms-530ms). There were 14 hospitalisations for metabolic crises. 57.1% had QTc interval prolongation, 35.7% ventricular tachycardias (4/14 monomorphic VT, 1/14 torsade de prongs) and 1/14 Brugada type 3 pattern. Three patients died in the context of severe metabolic acidosis and multi-organ involvement (2/12 due to VT and 1/12 due to cardiogenic shock, bradycardia associated with QTc of 635ms and severe ventricular dysfunction). CONCLUSIONS: In paediatric patients with TDD, the most frequent ECG abnormality was QTc interval prolongation with or without metabolic crises. There is a high risk of tachyarrhythmias, mainly VT, being the main cause of death in children with TDD. Subcutaneous Holter monitoring is recommended. During metabolic crises, there should be close ECG monitoring. Oxford University Press 2023-05-24 /pmc/articles/PMC10207009/ http://dx.doi.org/10.1093/europace/euad122.351 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle 13.5 - Prevention
Sarquella Brugada, G
Management of cardiac arrhythmias in paediatric patients with TANGO2-deficiency disorder
title Management of cardiac arrhythmias in paediatric patients with TANGO2-deficiency disorder
title_full Management of cardiac arrhythmias in paediatric patients with TANGO2-deficiency disorder
title_fullStr Management of cardiac arrhythmias in paediatric patients with TANGO2-deficiency disorder
title_full_unstemmed Management of cardiac arrhythmias in paediatric patients with TANGO2-deficiency disorder
title_short Management of cardiac arrhythmias in paediatric patients with TANGO2-deficiency disorder
title_sort management of cardiac arrhythmias in paediatric patients with tango2-deficiency disorder
topic 13.5 - Prevention
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207009/
http://dx.doi.org/10.1093/europace/euad122.351
work_keys_str_mv AT sarquellabrugadag managementofcardiacarrhythmiasinpaediatricpatientswithtango2deficiencydisorder